Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells

Pancreas

Volumn 19, Issue 3, 1999, Pages 281-288

  Kleeff, Jörg ^d   Wildi, Stefan ^d   Kumbasar, Asli ^a,b   Friess, Helmut ^c   Lander, Arthur D ^a   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d NONE

Author keywords

Antisense; Glypican 1; Growth factors; Heparin binding; Pancreatic cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLYPICAN; HEPARIN BINDING PROTEIN; SCATTER FACTOR;

ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOGENESIS; PANCREAS CANCER; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0032876483     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199910000-00009     Document Type: Article

References (43)

1. David G. Integral membrane heparan sulfate proteoglycans. FASEB J 1993;7:1023-30.
2. Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell BM 1992;8:365-93.
3. David G, Lorie V, Decock B, Marynen P, Cassiman J-J, Van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol 1990;111:3165-76.
4. Stipp CS, Litwack ED, Lander AD. Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. J Cell Biol 1994;124:149-60.
5. Filmus J, Church JG, Buick RN. Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol Cell Biol 1988;8:4243-9.
6. Watanabe K, Yamada H, Yamaguchi Y. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J Cell Biol 1995;130:1207-18.
7. Saunders S, Paine-Saunders S, Lander AD. Expression of the cell surface glypican-5 is developmentally regulated in kidney, limb, and brain. Dev Biol 1997;190:78-93.
8. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991;64: 841-8.
9. Bonneh-Barkey D, Shlissel M, Berman B, et al. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J Biol Chem 1997;272:12415-21.
10. Fukuda K, Inui Y, Kawata S, et al. Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic rats. Arterioscler Thromb Vasc Biol 1995;15:1680-7.
11. Sakata H, Stahl SJ, Taylor WG, et al. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms: heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem 1997;272:9457-63.
12. Liu W, Litwack ED, Stanley MJ, Langford JK, Lander AD, Sanderson RD. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules: syndecans and glypican have distinct functions. J Biol Chem 1998;273:22825-32.
13. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
14. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin North Am 1998;7:67-91.
15. Korc M. Growth factors in pancreatic cancer. In: Dervenis CG, ed. Advances in pancreatic disease. New York: Georg Thieme Verlag, 1996:34-41.
16. Yamanaka Y, Friess H, Büchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993;53:5289-96.
17. Ebert M, Yokoyama M, Kobrin MS, et al. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994;54:3959-62.
18. Kobrin MS, Funatomi H, Friess H, Büchler MW, Stathis P, Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994;202:1705-9.
19. Kornmann M, Ishiwata T, Beger HG, Korc M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 1997;15:1417-24.
20. Ebert M, Yokoyama M, Friess H, Büchler MW. Korc M. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994;54:5775-8.
21. Kleeff J, Ishiwata T, Kumbasar A, et al. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 1998;102:1662-73.
22. Raitano AB, Korc M. Tumor necrosis factor up-regulates γ-interferon binding in a human carcinoma cell line. J Biol Chem 1990; 265:10466-72.
23. Baldwin RL, Korc M. Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors 1993;8:23-34.
24. Kornmann M, Arber N, Korc M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 1998;101:344-52.
25. Wagner M, Lopez ME, Cahn M, Korc M. Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo. Gastroenterology 1998;114:798-807.
26. Wagner M, Cao T, Lopez ME, et al. Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. Int J Cancer 1996; 68:782-7.
27. Ivins JK, Litwack ED, Kumbasar A, Stipp CS, Lander AD. Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. Dev Biol 1997;184:320-32.
28. Litwack ED, Ivins JK, Kumbasar A, Paine-Saunders S, Stipp CS, Lander AD. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev Dynamics 1998;211:72-87.
29. Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991;252:1705-8.
30. Olwin BB, Rapraeger A. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J Cell Biol 1992;118:631-9.
31. Delhedde M, Deudon E, Boilly B, Hondermarck H. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells. Exp Cell Res 1996;229:398-406.
32. Roghani M, Mansukhani A, Dell'Era P, Bellosta P, Basilico C, Moscatelli D. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 1994;269:3976-84.
33. Spivak-Kroizman T, Lemmon MA, Dikic I, et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994;79:1015-24.
34. Pantoliano MW, Horlick RA, Springer BA, et al. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994;33:10229-48.
35. Schlessinger J, Lax I, Lemmon M, Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 1995;83:357-60.
36. Vlodavsky I, Miao H-Q, Medalion B, Danagher P, Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 1996;15:177-86.
37. Miyaza Y, Shinomura Y, Higashiyma S, et al. Heparin-binding EGF-like growth factor is an autocrine growth factor for rat gastric epithelial cells. Biochem Biophys Res Commun 1996;223: 36-41.
38. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007-11.
39. Korc M, Meltzer P, Trent J. Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Natl Acad Sci USA 1986;83: 5141-4.
40. Leung HY, Gullick WJ, Lemoine NR. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 1994;59:667-75.
41. Ebert M, Yokoyama M, Kobrin MS, et al. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994;54:3959-62.
42. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
43. Kumar R, Fidler IJ. Angiogenic molecules and cancer metastasis. In Vivo 1998;12:27-34.